Vanda Pharmaceuticals (VNDA) Insider Trading & Ownership $4.50 -0.09 (-1.96%) (As of 10/3/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Vanda Pharmaceuticals (NASDAQ:VNDA) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage7.70%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)1Amount OfInsider Selling(Last 12 Months)$13,325.92 Get VNDA Insider Trade Alerts Want to know when executives and insiders are buying or selling Vanda Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address VNDA Insider Buying and Selling by Quarter Ad Crypto 101 MediaNext opportunity for crypto millionsOctober isn't just another month in crypto. It's the launchpad for what could be the most explosive bull run in history. And I've found the rocket fuel… One coin is quietly positioning itself to outperform the entire market. The signs are everywhere…Go here to discover the coin that could define this historic bull run with gains kicking off this mo Vanda Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails7/29/2024Kevin Patrick MoranCFOSell2,251$5.92$13,325.92 (Data available from 1/1/2013 forward) VNDA Insider Trading Activity - Frequently Asked Questions Who is on Vanda Pharmaceuticals's Insider Roster? The list of insiders at Vanda Pharmaceuticals includes Joakim Wijkstrom, Kevin Patrick Moran, Mihael Hristos Polymeropoulos, Richard W Dugan, Stephen Ray Mitchell, and Timothy Williams. Learn more on insiders at VNDA. What percentage of Vanda Pharmaceuticals stock is owned by insiders? 7.70% of Vanda Pharmaceuticals stock is owned by insiders. Learn more on VNDA's insider holdings. Which Vanda Pharmaceuticals insiders have been selling company stock? The following insiders have sold VNDA shares in the last 24 months: Joakim Wijkstrom ($69,843.76), Kevin Patrick Moran ($228,611.80), Mihael Hristos Polymeropoulos ($645,756.98), Stephen Ray Mitchell ($39,325.00), and Timothy Williams ($204,502.88). How much insider selling is happening at Vanda Pharmaceuticals? Insiders have sold a total of 152,278 Vanda Pharmaceuticals shares in the last 24 months for a total of $1,188,040.42 sold. Vanda Pharmaceuticals Key ExecutivesDr. Mihael H. Polymeropoulos M.D. (Age 64)Founder, President, CEO & Chairman of The Board Compensation: $1.92MMr. Kevin Patrick Moran (Age 40)Senior VP, CFO & Treasurer Compensation: $815.54k1 recent tradesMr. Timothy Williams (Age 48)Senior VP, General Counsel & Secretary Compensation: $890.65kMr. Joakim Wijkstrom (Age 58)Senior VP & Chief Marketing Officer Compensation: $846.33kMr. Gunther Birznieks (Age 55)Senior Vice President of Business Development Compensation: $863.86kMr. Scott L. HowellChief People Officer More Insider Trading Tools from MarketBeat Related Companies: Gossamer Bio Insider Trading AnaptysBio Insider Trading OPKO Health Insider Trading Ironwood Pharmaceuticals Insider Trading Emergent BioSolutions Insider Trading Lexicon Pharmaceuticals Insider Trading XOMA Insider Trading Rigel Pharmaceuticals Insider Trading Codexis Insider Trading Sangamo Therapeutics Insider Trading Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: This Is the Top Large-Cap Stock Insiders Are BuyingMatador Resources Insiders Keep Buying Its Stock, Should You?Top 3 Small-Cap Stocks Insiders Are Buying Right Now3 Small Cap Stocks That Insiders Are BuyingMGM Insiders Bet Big on Its Undervalued Stock This page (NASDAQ:VNDA) was last updated on 10/3/2024 by MarketBeat.com Staff From Our PartnersKamala’s Dirty Election Move… RevealedAccording to former advisor to the CIA, the Pentagon and the White House Jim Rickards… Kamala and her puppe...Paradigm Press | SponsoredThe death of Nvidia?Today, I’m warning of another looming catastrophe. Only this time, it’s not in pot stocks, cryptos, or U.S....Porter & Company | SponsoredAI Expert Reveals New PickEveryone’s talking about AI right now, but I’ve been talking about it for years. And now I’ve just released...Brownstone Research | SponsoredNo matter the outcome of the election, it could be a death sentence for your wealth...In today's financial landscape, many investors are feeling disillusioned and disappointed with traditional inv...Allegiance Gold | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored44-year Wall Street Vet: “Permanent devastation is coming to America”After 44 years on Wall Street, I've seen it all... Black Monday, the Great Recession, the Covid crash. B...InvestorPlace | SponsoredMassive NVIDIA Sell-Off: Are We Headed for a Market Collapse?You may have heard about NVIDIA's CEO dumping shares of his own company. He sold 4.4 million shares this ye...Behind the Markets | SponsoredNext opportunity for crypto millionsAll the Pieces Falling into Place for Crypto… Unlock the Potential of the 2024 Crypto Bull Run!Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vanda Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vanda Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VNDA Stock Alerts